ESPAC-4 long-term follow-up: shall we choose gemcitabine and capecitabine as adjuvant therapy for elderly and low-risk pancreatic adenocarcinoma following surgical resection?
Fields of Study & Subjects
Pancreatic and Hepatic Oncology Research
Lung Cancer Research Studies
Gastric Cancer Management and Outcomes
Publication details
- Journal / source
- Annals of Pancreatic Cancer
- Publisher
- AME Publishing Company
- Volume
- 9
- Pages
- 1–1
- Publication date
- 1 January 2026